Key TakeawaysThe U.S. Food and Drug Administrtion is ending sale of compounded versions of Ozempic, Wegovy and similar ...

The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to ...

The suit comes amid recent studies showing a link between vision complications and people taking drugs containing semaglutide ...

Starting today, pharmacies can no longer make cheaper alternatives to popular weight loss drugs, driving up costs for ...

Forget the needle.

Dozens of Ozempic and Wegovy users have reported suffering from eye disorders they claim are associated with the drugs, ...

Many people using GLP-1 weight-loss drugs like Ozempic, Wegovy or Mounjaro regain the weight after stopping-experts explain ...

New research has shown that Ozempic can cause taste changes in people taking it, even going so far as to make some hate the ...

The Royal College of GPs’ weight loss expert has sounded a warning bell for users of popular drugs Ozempic, Mounjaro and ...

Boards, Policy & Regulationcategory· February 24, 2025 Drug compounders sue US FDA over removal of Wegovy, Ozempic from shortage list Drug compounders sued the U.S. Food and Drug Administration ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

respectively), as well as two pertaining to Ozempic/Wegovy and one pertaining to Mounjaro ("new" medications, approved for weight loss in 2021 and 2023, respectively). Steffen Trumpf/picture ...